Prevalence of Cardiovascular Comorbidities in Patients with Rheumatoid Arthritis

Marius Rus1,2, Adriana Ioana Ardelean2,3, Claudia Judea Pusta2,4

  • 1Department of Medical Disciplines, Faculty of Medicine and Pharmacy, University of Oradea, 410073 Oradea, Romania.

PubMed

Insights

Rheumatoid arthritis patients face double the cardiovascular disease risk. Women with RA have higher risks of atrial fibrillation and pulmonary hypertension, while men show elevated cholesterol levels.

Area of Science:

  • Rheumatology
  • Cardiology
  • Internal Medicine

Background:

  • Rheumatoid arthritis (RA) significantly elevates cardiovascular disease (CVD) risk, doubling it compared to the general population.
  • Early diagnosis and management of RA are crucial, especially for young patients, to mitigate CVD progression and maintain an active lifestyle.

Purpose of the Study:

  • To investigate gender-specific cardiovascular complications in patients with rheumatoid arthritis.
  • To assess traditional and non-traditional risk factors, and electrocardiographic/echocardiographic findings in male and female RA patients.

Main Methods:

  • Retrospective study of 200 rheumatoid arthritis patients (124 women, 76 men) with cardiovascular complications.
  • Assessment of risk factors, electrocardiographic, and echocardiographic data stratified by gender.

Main Results:

  • All patients exhibited an atherogenic coefficient >2, indicating high atherogenesis risk.
  • Men showed higher total cholesterol levels (77.6%) than women (25.8%).
  • Women had a 2.3-fold increased risk of atrial fibrillation and higher incidence of pulmonary arterial hypertension compared to men.

Conclusions:

  • Rheumatoid arthritis screening is often insufficient, leading to undiagnosed cases and unaddressed risk factors.
  • RA patients remain at elevated risk for developing cardiovascular diseases due to inadequate screening and risk factor assessment.

Related Concept Videos

Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
31
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
343
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.8K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
93
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
2.8K
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.3K